Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Knowing when to save money and when to invest is vital for financial success. This article provides insights on timing your decisions.
28,655 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
The Nasdaq Composite extended gains as bulls maintain control amid stronger tech deal activity, improving chip profit...
A veteran market observer argues that timing the market is a losing bet. New data shows the cost of waiting and the b...
Inflation surprised to the upside in April, reviving debate over Fed policy and sending Bitcoin lower as higher yield...
A high-profile clash between the Pentagon and a leading AI firm hits markets and wallets. Regulators, investors, and ...
Yorkville America pulled Truth Social crypto ETF filings, signaling a pivot to the 40 Act structure. Analysts debate ...
EU officials warn that energy prices will remain higher than pre-war levels through 2027 as the Iran conflict keeps i...
Homeowners are seeing a sharp drop in market values while property tax assessments lag, pushing bills higher even as ...
A veteran market strategist argues the semiconductor rally is supported by real demand and capacity constraints, not ...
Tokenized equities reach $5.5B market value this week, driven by SpaceX IPO access and expanding exchange support. An...
SpaceX's blockbuster IPO drew record demand and about $75 billion in funding, but tokenized pre-offers fell short for...
Bitcoin moved lower amid regulatory headlines, with Bybit added to MAS alert and Binance MiCA hurdles dominating the ...